Universal Diagnostics SL articles

Background
Pancreatic cancer is one of the highest mortality rate cancers worldwide with 5-year relative survival of 10.8%. Lack of screening methods for early-stage detection as well as proper patient sub-characterization, make it a fatal cancer due to poor diagnoses and insufficient treatment.

Methylation flags are kept on tumorigenesis, akin to the tissue-specific traces that are acquired and maintained throughout development. Methylomes have been explored all

A study of Universal Diagnostics` blood-based colorectal cancer test found it was more than 90 percent accurate, the company announced June 3.

The blood test was found to detect colorectal cancer with 92 percent sensitivity and 97 percent specificity. It also was shown to have 89 percent sensitivity and 97 percent specificity detecting early-stage ca

SEVILLE, Spain--(BUSINESS WIRE)--Universal Diagnostics (UDX), an in-vitro diagnostics company developing minimally-invasive, blood-based solutions for detecting cancer ear

NEW YORK - Spanish cancer research firm Universal Diagnostics is gearing up to commercialize a liquid biopsy test that applies methylation biomarkers to detect lung cancer, based on data presented at the International Association for the Study of Lung Cancer 2020 World Conference for Lung Cancer (WCLC) last month.

The Seville-based firm also expects to release clinical data on its next generation sequencing-based colorectal cancer (CRC) assay later this year.

Christian Hense,